GSTP1 arrests bladder cancer T24 cells in G0/G1 phase and up-regulates p21 expression

被引:0
作者
Gao, Li [1 ]
Fang, You-Qiang [2 ]
Zhang, Tian-Yu
Ge, Bo [1 ]
Xu, Bin [1 ]
Huang, Jie-Fu [1 ]
Zhang, Zhen-Feng [4 ]
Tan, Ning [3 ]
机构
[1] Guilin Med Coll, Affiliated Hosp, Dept Urol, Guilin 541004, Guangxi, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Urol, Guangzhou 510630, Guangdong, Peoples R China
[3] Guilin Med Coll, Ctr Sci Res, Guilin 541004, Guangxi, Peoples R China
[4] Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200032, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE | 2014年 / 7卷 / 09期
基金
中国国家自然科学基金;
关键词
Bladder cancer; GSTP1; cell proliferation; cell cycle; p2;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective: GSTP1 over-expression was introduced into human bladder cancer T24 cells via the lentivirus system. The influence of GSTP1 on the proliferation and cell cycle of T24 cells as well as the potential mechanisms was investigated. Methods: The lentiviral vector GSTP1-pWPXL was constructed and transfected into T24 cells in the presence of Lipofectamine 2000. CCK8 assay and colony formation test were performed to explore the impact of GSTP1 on the proliferation of T24 cells. Ollowing PI staining, flow cytometry was done to detect the proportion of T24 cells in different phases. Western blot assay was conducted to detect the protein p21 expression. Results: When compared with control group, T24 cells with GSTP1 over-expression showed significant reduction in cell proliferation (P < 0.01) and they were arrested in G0/G1 phase. Western blot assay indicated that the p21 protein expression in T24 cells with GSTP1 over-expression was significantly higher than that in control group. Conclusion: GSTP1 may inhibit the proliferation of T24 cells and arrest these cells in G0/G1 phase, which may be ascribed to the up-regulated expression of p21.
引用
收藏
页码:2984 / 2991
页数:8
相关论文
共 9 条
  • [1] ATP-noncompetitive CDK inhibitors for cancer therapy: an overview
    Abate, Agnese Anna
    Pentimalli, Francesca
    Esposito, Luca
    Giordano, Antonio
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (07) : 895 - 906
  • [2] p21 in cancer: intricate networks and multiple activities
    Abbas, Tarek
    Dutta, Anindya
    [J]. NATURE REVIEWS CANCER, 2009, 9 (06) : 400 - 414
  • [3] Multiple roles of the cell cycle inhibitor p21CDKN1A in the DNA damage response
    Cazzalini, Ornella
    Scovassi, A. Ivana
    Savio, Monica
    Stivala, Lucia A.
    Prosperi, Ennio
    [J]. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2010, 704 (1-3) : 12 - 20
  • [4] Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts
    Kolfschoten, GM
    Hulscher, TM
    Pinedo, HM
    Boven, E
    [J]. BRITISH JOURNAL OF CANCER, 2000, 83 (07) : 921 - 927
  • [5] Koltovaya N A, 2013, Genetika, V49, P797
  • [6] Liu ZM, 2003, MILIT MED J S CHINA, V17, P9
  • [7] Dual effects of glutathione-S-transferase π on As2O3 action in prostate cancer cells:: enhancement of growth inhibition and inhibition of apoptosis
    Lu, M
    Xia, LJ
    Luo, D
    Waxman, S
    Jing, YK
    [J]. ONCOGENE, 2004, 23 (22) : 3945 - 3952
  • [8] Cancers of the bladder
    Sengupta, N
    Siddiqui, E
    Mumtaz, FH
    [J]. JOURNAL OF THE ROYAL SOCIETY FOR THE PROMOTION OF HEALTH, 2004, 124 (05): : 228 - 229
  • [9] [王健 Wang Jian], 2005, [中国药物化学杂志, Chinese Journal of Medicinal Chemistry], V15, P251